Emmi Vakkila

Imatinib and pegylated IFN‐α2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response

S. Mustjoki, K. Porkka, A. Kreutzman, 2014, European journal of haematology.

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

D. Greco, S. Mustjoki, J. Cayuela, 2012, Experimental hematology.

Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia

S. Knuutila, N. Mosakhani, M. Missiry, 2017, Journal of pediatric hematology/oncology.

Apraxia and dementia severity in Alzheimer’s disease: a systematic review

M. Jehkonen, Emmi Vakkila, 2023, Journal of clinical and experimental neuropsychology.